FRIDAY, May 12, 2023 (HealthDay News) — Outside advisors for the U.S. Food and Drug Administration voted Thursday to recommend approval of Neffy, the first epinephrine nasal spray for severe allergic reactions. Although most of the Pulmonary-Allergy Drugs Advisory Committee members supported the spray for adults (16:6) and children (17:5),Continue Reading

WEDNESDAY, April 19, 2023 (HealthDay News) — Summer is almost here, and its arrival brings opportunities for many people – including those who suffer with allergies and asthma — to plan vacations away from home. A recent article titled “Allergies don’t take a vacation” in Annals of Allergy, Asthma &Continue Reading

MONDAY, April 10, 2023 (HealthDay News) — Seasonal allergies are more common among Black and Hispanic people, but these patients are less likely to get the shots that could ease their symptoms, researchers say. “We already know that these underrepresented populations are more likely to suffer from allergic rhinitis [hayContinue Reading

MONDAY, April 3, 2023 (HealthDay News) – Pope Francis was back delivering Mass on Palm Sunday, just one day after he was released from the hospital following a three-day stay for bronchitis. Francis, 86, celebrated in St. Peter’s Square in Rome as about 60,000 people looked on, carrying palm frondsContinue Reading

FRIDAY, March 31, 2023 (HealthDay News) — Cats constantly licking and chewing because of a skin condition called feline allergic dermatitis may benefit from a new generic treatment approved by the U.S. Food and Drug Administration. The FDA approved Modulis for Cats on March 29, making it the first genericContinue Reading